Deep Vein Thrombosis
Deep vein thrombosis (DVT) is the formation of a blood clot in one of the deep veins, most often in the legs but sometimes in the pelvis, arms, or other locations. DVT is a common and potentially serious condition because clots can break off and travel to the lungs, causing pulmonary embolism. It can also produce long-term complications such as post-thrombotic syndrome. Ultrasound is the primary imaging tool for diagnosis, and treatment combines anticoagulation, supportive care, and identification of underlying risk factors.
What is it?
The deep veins are the large veins located within the muscles of the limbs and the pelvis, where most of the blood is returned to the heart. They are distinct from the superficial veins located closer to the skin. Deep vein thrombosis is the formation of a blood clot (thrombus) in one of these deep veins. DVT most often occurs in the deep veins of the calf, thigh, or pelvis but can also affect the veins of the arms, shoulders, abdomen, or other locations.
DVT develops when conditions favor the formation of a clot, classically described by Virchow’s triad: slowed blood flow (such as during prolonged immobility), injury to the vein wall (from surgery, trauma, or central line catheters), and increased clotting tendency (from genetic, hormonal, or acquired factors). Major risk factors include prior DVT or pulmonary embolism, recent surgery (particularly of the hip, knee, abdomen, or pelvis), prolonged immobility (such as long hospital stays, illness with bed rest, or extended travel), cancer (which increases clotting risk both directly and through treatment), pregnancy and the postpartum period, hormonal therapy (oral contraceptives or hormone replacement), inherited thrombophilias (such as factor V Leiden or prothrombin gene mutation), and antiphospholipid antibody syndrome. Other contributors include older age, obesity, smoking, severe infection, certain medical conditions (such as inflammatory bowel disease, nephrotic syndrome, and heart failure), central venous catheters, and previous radiation.
DVT can be classified by location. Proximal DVTs involve the veins of the thigh and pelvis (such as the femoral, popliteal, and iliac veins) and are associated with a higher risk of pulmonary embolism. Distal DVTs involve the deep veins of the calf and generally have a lower risk of embolism. Upper extremity DVT involves the deep veins of the arm and shoulder and is often associated with catheters, cancer, or anatomic compression (such as in thoracic outlet syndrome). Special forms include pelvic vein thrombosis (which can be more difficult to detect), abdominal vein thrombosis (such as portal or hepatic vein thrombosis), and uncommon sites such as cerebral venous sinus thrombosis.
The classic symptoms of DVT include swelling of the affected limb (often greater on one side than the other), pain or tenderness (sometimes worse with walking or pressure on the calf), warmth, redness or bluish discoloration, a feeling of heaviness, and visible enlargement of surface veins. Some DVTs cause no symptoms and are discovered only because of complications such as pulmonary embolism or on imaging done for other reasons. The most serious immediate complication of DVT is pulmonary embolism, in which a clot breaks off and travels through the bloodstream to the lungs, where it can cause sudden shortness of breath, chest pain, low blood pressure, or, in severe cases, cardiac arrest. Long-term complications include post-thrombotic syndrome, in which damaged vein valves lead to chronic leg swelling, pain, skin changes, and, sometimes, ulcers.
Doppler ultrasound is the primary imaging tool for evaluating suspected DVT of the legs and arms because it is widely available, accurate, noninvasive, and does not require contrast. CT venography and MR venography are particularly useful for clots in the pelvis, abdomen, or other locations where ultrasound is less effective. The D-dimer blood test is often used in patients with lower clinical suspicion; a normal D-dimer can help rule out DVT without imaging, while an elevated value is less specific and typically prompts further evaluation. Blood tests for underlying clotting disorders may be considered in selected patients, particularly when DVT occurs at a young age, in unusual locations, with recurrent events, or in families with strong clotting histories.
Important to Know
The mainstay of DVT treatment is anticoagulation with blood-thinning medications, which prevents the clot from growing, reduces the risk of pulmonary embolism, and supports the body’s natural process of dissolving and stabilizing the clot. Several classes of anticoagulants are available, including direct oral anticoagulants (DOACs), low-molecular-weight heparin, warfarin, and others. The choice depends on individual factors such as kidney function, pregnancy, cancer, bleeding risk, and patient preferences.
The duration of anticoagulation depends on the circumstances of the DVT. Provoked DVTs (clearly related to a temporary risk factor such as surgery, immobility, or trauma) often require shorter courses, typically several months. Unprovoked DVTs, recurrent events, ongoing risk factors (such as active cancer), or certain inherited clotting conditions may require longer or indefinite anticoagulation. Decisions are individualized and made in collaboration with hematologists, vascular medicine specialists, primary care clinicians, and other relevant providers.
For severe or limb-threatening DVTs, more aggressive treatments may be considered, including catheter-directed thrombolysis, mechanical thrombectomy, or surgery. Phlegmasia cerulea dolens—a severe form of DVT in which extensive clotting threatens limb viability—is a vascular emergency that requires urgent treatment. Patients who cannot tolerate anticoagulation or who develop recurrent emboli despite adequate treatment may be considered for inferior vena cava (IVC) filters.
Supportive care plays an important role. Compression stockings can help reduce swelling and discomfort during the acute phase and may help reduce the risk of post-thrombotic syndrome in selected patients. Leg elevation, gentle activity (walking is often encouraged rather than bed rest), pain management, and treatment of underlying conditions are also important.
Prevention of DVT is critical in high-risk situations. This includes the use of mechanical compression devices and pharmacologic prophylaxis (with low-dose anticoagulants) during and after surgery, during hospitalization for acute illness, and in other high-risk circumstances. Travelers and others with prolonged immobility benefit from frequent movement, calf exercises, hydration, and, in selected patients, compression stockings.
Long-term follow-up after DVT is important to monitor for symptoms of post-thrombotic syndrome, adjust treatment, and address ongoing risk factors. Patients with recurrent or unprovoked DVT may benefit from evaluation for inherited or acquired clotting disorders.
Care is typically coordinated by primary care clinicians, hematologists, vascular medicine specialists, vascular surgeons, interventional radiologists, and other relevant providers. Patient education is essential, both for recognizing symptoms of pulmonary embolism and for adhering to anticoagulation safely.
Red flag symptoms include sudden severe shortness of breath, severe chest pain, fainting, coughing up blood, rapid heart rate with confusion or low blood pressure, severe limb pain with blue or pale discoloration, signs of acute limb threat, or any new neurological symptoms. These warrant immediate emergency evaluation, as they may indicate pulmonary embolism, severe DVT, or another serious complication.